Composition
- Active ingredients
- CEPHRADINE 500MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CEPHRADINE 125MG/5ML · For suspensionANDA062693-001 · Discontinued
- CEPHRADINE 250MG/5ML · For suspensionANDA062693-002 · Discontinued
- CEPHRADINE 250MG · CapsuleANDA062762-001 · Discontinued
- CEPHRADINE 500MG · CapsuleANDA062762-002 · Discontinued
- CEPHRADINE 500MG · CapsuleANDA062851-001 · Discontinued
- CEPHRADINE 250MG · CapsuleANDA062850-001 · Discontinued
- CEPHRADINE 250MG/5ML · For suspensionANDA062859-001 · Discontinued
- CEPHRADINE 250MG · CapsuleANDA062813-001 · Discontinued
- CEPHRADINE 500MG · CapsuleThis page
- CEPHRADINE 125MG/5ML · For suspensionANDA062858-001 · Discontinued
- CEPHRADINE 500MG · CapsuleANDA062683-002 · Discontinued
- CEPHRADINE 250MG · CapsuleANDA062683-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA062813.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Cephradine
- Route
- Oral
- Dosage form
- Capsule
- Applicant
- Vitarine
- Status
- Discontinued
- Application
- ANDA062813-002



